Rigel Pharmaceuticals Inc (RIGL)
Cost of Revenue
$23.84M
TTM · Period ending: · USD
RIGL Cost of Revenue
Latest reported$23.84Mperiod ending
Latest reported$23.84Mperiod ending
RIGL TTM Cost of Revenue ($0.00 → $23.84M)
TTM cost of revenue
High-resolution chart · PNG
RIGL cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 23,839,000 | |
| 19,818,000 | |
| 19,621,000 | |
| 19,455,000 | |
| 22,728,000 | |
| 21,031,000 | |
| 18,647,000 | |
| 16,648,000 | |
| 9,890,000 | |
| 8,158,000 | |
| 7,110,000 | |
| 3,662,000 | |
| 2,644,000 | |
| 2,605,000 | |
| 1,749,000 | |
| 1,894,000 | |
| 1,795,000 | |
| 888,000 | |
| 1,083,000 | |
| 917,000 | |
| 906,000 | |
| 1,056,000 | |
| 895,000 | |
| 752,000 | |
| 922,000 | |
| 954,000 | |
| 906,000 | |
| 916,000 | |
| 675,000 | |
| 394,000 | |
| 11,529,000 | |
| 22,902,000 | |
| 33,641,000 | |
| 45,135,000 | |
| 46,269,000 | |
| 46,342,000 | |
| 51,705,000 | |
| 57,649,000 | |
| 63,446,000 | |
| 68,375,000 | |
| 67,705,000 | |
| 65,296,000 | |
| 62,825,000 | |
| 60,875,000 | |
| 61,525,000 | |
| 66,529,000 | |
| 67,696,000 | |
| 71,129,000 | |
| 72,552,000 | |
| 71,882,000 | |
| 75,328,000 | |
| 77,046,000 | |
| 79,658,000 | |
| 60,265,000 | |
| 39,950,000 | |
| 20,186,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -817,000 | |
| -817,000 |